Low expression of exosomal miR-150 predicts poor prognosis in colorectal cancer patients after surgical resections. 2022

Yong Zhang, and Wen-Shuai Liu, and Xiang-Yu Zhang, and Han-Xing Tong, and Hua Yang, and Wei-Feng Liu, and Jia Fan, and Jian Zhou, and Jie Hu
Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.

Liver metastasis is a leading indicator of poor prognosis in patients with colorectal cancer (CRC). Exosomal intercellular communication has been reported to play an important role in cancer invasion and metastasis. Here, we characterized exosomal miRNAs underlying liver metastasis in CRC patients (Cohort 1, n = 30) using miRNA arrays. Exosomal miR-150 was found to be downregulated in CRC patients with liver metastases compared to those without (P = 0.025, fold change [FC] = 2.01). These results were then validated using another independent cohort of CRC patients (Cohort 2, n = 64). Patients with low expression of exosomal miR-150 had significantly shorter overall survival (OS) time (33.3 months versus 43.3 months, P = 0.002). In addition, the low expression of exosomal miR-150 was significantly correlated with advanced tumor node metastasis staging (P = 0.013), higher CA199 level (P = 0.018), and the presence of liver metastasis (P = 0.048). Multivariate analysis showed that low expression of exosomal miR-150 (P = 0.035) and liver metastasis (P < 0.001) were independent prognostic factors for overall survival. In vivo and in vitro studies showed that the viability and invasion of CRC cells were both significantly suppressed by ExomiR-150. Target-prediction assessment and dual-luciferase reporter assay indicated that FTO (the fat mass and obesity-associated gene) was a direct target for miR-150. This study first demonstrated that exosomal miR-150 may be a potential prognostic factor and treatment target for CRC.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000071516 Alpha-Ketoglutarate-Dependent Dioxygenase FTO A dioxygenase that repairs alkylated DNA and RNA by oxidative demethylation. It has highest activity towards single-stranded RNA containing 3-methyluracil, followed by SINGLE-STRANDED DNA containing 3-methylthymine and specifically demethylates N(6)-methyladenosine (m6A) RNA, the most common internal modification of MESSENGER RNA (mRNA) in higher EUKARYOTES. It contributes to the regulation of the global metabolic rate, energy HOMEOSTASIS, as well as body fat accumulation by regulating the differentiation of ADIPOCYTES into BROWN FAT CELLS or WHITE FAT CELLS. AlkB Homolog 9 Protein,Alpha-Ketoglutarate-Dependent Dioxygenase,Fat Mass and Obesity Associated (FTO) Protein,Fat Mass and Obesity Associated Protein,Alpha Ketoglutarate Dependent Dioxygenase,Alpha Ketoglutarate Dependent Dioxygenase FTO,Dioxygenase, Alpha-Ketoglutarate-Dependent,FTO, Alpha-Ketoglutarate-Dependent Dioxygenase
D015179 Colorectal Neoplasms Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. Colorectal Cancer,Colorectal Carcinoma,Colorectal Tumors,Neoplasms, Colorectal,Cancer, Colorectal,Cancers, Colorectal,Carcinoma, Colorectal,Carcinomas, Colorectal,Colorectal Cancers,Colorectal Carcinomas,Colorectal Neoplasm,Colorectal Tumor,Neoplasm, Colorectal,Tumor, Colorectal,Tumors, Colorectal
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D055354 Exosomes A type of extracellular vesicle, containing RNA and proteins, that is secreted into the extracellular space by EXOCYTOSIS when MULTIVESICULAR BODIES fuse with the PLASMA MEMBRANE.
D035683 MicroRNAs Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing. RNA, Small Temporal,Small Temporal RNA,miRNA,stRNA,Micro RNA,MicroRNA,Primary MicroRNA,Primary miRNA,miRNAs,pre-miRNA,pri-miRNA,MicroRNA, Primary,RNA, Micro,Temporal RNA, Small,miRNA, Primary,pre miRNA,pri miRNA

Related Publications

Yong Zhang, and Wen-Shuai Liu, and Xiang-Yu Zhang, and Han-Xing Tong, and Hua Yang, and Wei-Feng Liu, and Jia Fan, and Jian Zhou, and Jie Hu
January 2019, Cancer biomarkers : section A of Disease markers,
Yong Zhang, and Wen-Shuai Liu, and Xiang-Yu Zhang, and Han-Xing Tong, and Hua Yang, and Wei-Feng Liu, and Jia Fan, and Jian Zhou, and Jie Hu
January 2014, International journal of clinical and experimental pathology,
Yong Zhang, and Wen-Shuai Liu, and Xiang-Yu Zhang, and Han-Xing Tong, and Hua Yang, and Wei-Feng Liu, and Jia Fan, and Jian Zhou, and Jie Hu
September 2017, Oncotarget,
Yong Zhang, and Wen-Shuai Liu, and Xiang-Yu Zhang, and Han-Xing Tong, and Hua Yang, and Wei-Feng Liu, and Jia Fan, and Jian Zhou, and Jie Hu
January 2016, Medical science monitor : international medical journal of experimental and clinical research,
Yong Zhang, and Wen-Shuai Liu, and Xiang-Yu Zhang, and Han-Xing Tong, and Hua Yang, and Wei-Feng Liu, and Jia Fan, and Jian Zhou, and Jie Hu
January 2018, International journal of clinical and experimental pathology,
Yong Zhang, and Wen-Shuai Liu, and Xiang-Yu Zhang, and Han-Xing Tong, and Hua Yang, and Wei-Feng Liu, and Jia Fan, and Jian Zhou, and Jie Hu
July 2019, Clinical and experimental pharmacology & physiology,
Yong Zhang, and Wen-Shuai Liu, and Xiang-Yu Zhang, and Han-Xing Tong, and Hua Yang, and Wei-Feng Liu, and Jia Fan, and Jian Zhou, and Jie Hu
July 2017, Cancer biomarkers : section A of Disease markers,
Yong Zhang, and Wen-Shuai Liu, and Xiang-Yu Zhang, and Han-Xing Tong, and Hua Yang, and Wei-Feng Liu, and Jia Fan, and Jian Zhou, and Jie Hu
January 2015, International journal of clinical and experimental pathology,
Yong Zhang, and Wen-Shuai Liu, and Xiang-Yu Zhang, and Han-Xing Tong, and Hua Yang, and Wei-Feng Liu, and Jia Fan, and Jian Zhou, and Jie Hu
May 2018, Cancer biomarkers : section A of Disease markers,
Yong Zhang, and Wen-Shuai Liu, and Xiang-Yu Zhang, and Han-Xing Tong, and Hua Yang, and Wei-Feng Liu, and Jia Fan, and Jian Zhou, and Jie Hu
January 2014, International journal of clinical and experimental pathology,
Copied contents to your clipboard!